THE HOST RESPONSE IN GRAFT-VERSUS-HOST DISEASE .3. THE IN-VITRO INDUCTION OF REGULATORY CELLS IN CHRONIC MURINE GRAFT-VERSUS-HOST DISEASE

被引:3
|
作者
MANN, RA
SINGH, AB
JETZT, AE
SINGH, M
机构
[1] Division of Nephrology, Department of Medicine, University of Medicine, Dentistry of New Jersey-Robert Wood Johnson, New Brunswick
关键词
D O I
10.1006/cimm.1995.1136
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Murine graft versus host (GVH) disease takes two forms depending upon the parental/F1 strain combination employed, Acute lethal GVH disease is characterized by anemia, lymphopenia, hypogammaglobulinemia, profound anti-F1 cytotoxicity, and the loss of cytotoxic potential against third-party alloantigen. In contrast to this, chronic GVH disease is characterized by polyclonal B cell activation, autoantibody production, no anti-F1 cytotoxicity, and retained cytotoxicity against allotargets. We have previously reported that this marked disparity in disease expression results from a radiosensitive host cell which protects the F1 mouse from parental anti-F1 CTX in mice undergoing CGVH disease, Using an in vitro system to induce the host protective cell, we now demonstrate that two distinct Thy-1(+) cells emerge which regulate CTX against the host. One cell is of host origin, radiation sensitive, and functionally resembles a veto cell, The second regulatory cell, of parental origin, is radiation resistant and restricted in its ability to suppress anti-F1 CTX: We further demonstrate that the emergence of these cells is modulated by competitive immunoregulatory influences mediated by T contrasuppressor and I-J(+) cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME - RESPONSE
    YEAGER, AM
    BLOOD, 1992, 80 (11) : 2949 - 2950
  • [2] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME
    BEYER, J
    SCHWERDTFEGER, R
    SIEGERT, W
    BLOOD, 1992, 80 (11) : 2948 - 2949
  • [3] Chronic graft-versus-host disease
    Rorvik, Synne Dragesund
    Abrahamsen, Ingerid Weum
    Myhre, Anders Eivind
    Vo, Camilla Dao
    Odegaard, Eva Meling
    Bruserud, Oystein
    Gedde-Dahl, Tobias
    Tvedt, Tor Henrik Anderson
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (04) : 337 - 341
  • [4] Chronic graft-versus-host disease
    Bolanos-Meade, Javier
    Vogelsang, Georgia B.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (20) : 1974 - 1986
  • [5] Chronic graft-versus-host disease
    Galbizo, Ellaine
    Williams, Lori A.
    ONCOLOGY NURSING FORUM, 2006, 33 (05) : 881 - 883
  • [6] Chronic graft-versus-host disease
    Cutler, C
    Antin, JH
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) : 126 - 131
  • [7] Chronic graft-versus-host disease
    Margolis, J
    Vogelsang, G
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 339 - 346
  • [8] CHRONIC GRAFT-VERSUS-HOST DISEASE
    ATKINSON, K
    BONE MARROW TRANSPLANTATION, 1990, 5 (02) : 69 - 82
  • [9] Chronic graft-versus-host disease
    Horwitz, ME
    Sullivan, KM
    BLOOD REVIEWS, 2006, 20 (01) : 15 - 27
  • [10] Chronic graft-versus-host disease
    Lee, SJ
    Vogelsang, G
    Flowers, MED
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (04) : 215 - 233